R. Callies - Concepedia

Author

R. Callies

University of Duisburg-Essen

Also Known As

R Callies, R. Callies, R. P. Callies, Rainer Callies

142

Publications

640

Citations

H-Index

Concepts

All Affiliations

University of Duisburg-Essen Essen University Hospital West German Heart and Vascular Center Essen German Cancer Research Center Heidelberg University

About

R. Callies is an author at University of Duisburg-Essen specializing in medicine, breast cancer, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	329
2	Cell Biology	4	4	198
3	Endocrinology	2	2	99
4	Obstetrics	2	2	99
5	Public Health	1	1	16

R. Callies

Publications

567

Citations

H-Index

Page 1

	Year	Citations
Prognostic relevance of activated Akt kinase in node-negative breast cancer: a clinicopathological study of 99 cases Klaus J. Schmitz, Friedrich Otterbach, R. Callies, Modern Pathology Breast OncologyMedicinePrognostic RelevancePathologyBreast Cancer	2003	88
Aromatase inhibition with 4-hydroxyandrostenedione in the treatment of postmenopausal patients with advanced breast cancer: a phase II study. K. Höffken, W. Jonat, K. Possinger, Journal of Clinical Oncology Breast OncologyAromatase InhibitionGynecologyPhase Ii StudyPharmacotherapy	1990	83
High expression of focal adhesion kinase (p125FAK) in node-negative breast cancer is related to overexpression of HER-2/neu and activated Akt kinase but does not predict outcome Klaus J. Schmitz, Florian Grabellus, R. Callies, Breast Cancer Research	2005	73
Aquaporin 1 (AQP1) expression is a novel characteristic feature of a particularly aggressive subgroup of basal-like breast carcinomas Friedrich Otterbach, R. Callies, Michael Adamzik, Breast Cancer Research and Treatment Basal-like Breast CarcinomasBreast OncologyAggressive SubgroupPathologyNovel Characteristic Feature	2009	71
The AA Genotype of the Regulatory <i>BCL2</i> Promoter Polymorphism (−938C&gt;A) Is Associated with a Favorable Outcome in Lymph Node–Negative Invasive Breast Cancer Patients Hagen S. Bachmann, Friedrich Otterbach, R. Callies, Clinical Cancer Research	2007	49
Overexpression of cyclo-oxygenase-2 is an independent predictor of unfavourable outcome in node-negative breast cancer, but is not associated with protein kinase B (Akt) and mitogen-activated protein kinase (ERK1/2, p38) activation or with Her-2/neu signalling pathways Klaus J. Schmitz, R. Callies, Jeremias Wohlschlaeger, Journal of Clinical Pathology	2006	35
Expression of the cell adhesion molecules ICAM-1 and VCAM-1 in the cytosol of breast cancer tissue, benign breast tissue and corresponding sera. Regidor Pa, R. Callies, M. Regidor, PubMed	1998	34
The T393C polymorphism in the gene GNAS1 of G protein is associated with survival of patients with invasive breast carcinoma Friedrich Otterbach, R. Callies, Ulrich H. Frey, Breast Cancer Research and Treatment T393c PolymorphismTumor BiologyBreast OncologyMedicineG Protein	2006	32
expression of the cd44 variant isoforms 6 and 4/5 in breast cancer correlation with established prognostic parameters Pedro‐Antonio Regidor, R. Callies, M. Regidor, Archives of Gynecology and Obstetrics Tumor BiologyBreast Cancer CorrelationOncologyBreast OncologyPrognostic Parameters	1996	20
Relationship and prognostic significance of phospho-(serine 166)-murine double minute 2 and Akt activation in node-negative breast cancer with regard to p53 expression Klaus J. Schmitz, Florian Grabellus, R. Callies, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin Breast OncologyMedicineAkt ActivationSerine 166Pathology	2005	19

Page 1